XML 99 R87.htm IDEA: XBRL DOCUMENT
v3.22.1

LEGAL PROCEEDINGS - Intellectual Property (Details) |  |  |  | 1 Months Ended |
--- | --- | --- | --- | --- | ---
Aug. 28, 2020 | May 01, 2020 | Mar. 26, 2020 | Apr. 30, 2021 | Mar. 31, 2022 defendant claim
Norwich Pharmaceuticals Inc. Litigation |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Stay of approval, period |  |  | 30 months |  |
Perrigo Israel Pharmaceuticals, Ltd. Litigation |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Stay of approval, period | 30 months |  |  |  |
Padagis Litigation |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Stay of approval, period |  | 30 months |  |  |
MSN Laboratories Private Ltd. Litigation |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Stay of approval, period |  |  |  | 30 months |
Patent Infringement Litigation | Canada |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Number of separate defendants | defendant |  |  |  |  | 4
Apotex Inc. Litigation | Canada | Pending Litigation |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Number of lawsuits pending | claim |  |  |  |  | 2

X
- Definition Loss Contingency, Number Of Separate Defendants + References No definition available. + Details
Name: | bhc_LossContingencyNumberOfSeparateDefendants
Namespace Prefix: | bhc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Stay Of Approval, Period + References No definition available. + Details
Name: | bhc_LossContingencyStayOfApprovalPeriod
Namespace Prefix: | bhc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_LitigationCaseAxis=bhc_NorwichPharmaceuticalsIncLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_PerrigoIsraelPharmaceuticalsLtdLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_PadagisLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_MSNLaboratoriesPrivateLtdLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_PatentInfringementLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_CA
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=bhc_ApotexIncLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |